NKGen Biotech Inc
NASDAQ:NKGN
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| US |
N
|
NKGen Biotech Inc
NASDAQ:NKGN
|
7.5m USD |
Loading...
|
|
| IN |
A
|
Aaswa Trading and Exports Ltd
BSE:512038
|
26.9T INR |
Loading...
|
|
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
193.6B USD |
Loading...
|
|
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR |
Loading...
|
|
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD |
Loading...
|
|
| US |
|
Schlumberger NV
NYSE:SLB
|
72B USD |
Loading...
|
|
| US |
B
|
Baker Hughes Co
NASDAQ:BKR
|
55.2B USD |
Loading...
|
|
| IN |
G
|
GTV Engineering Ltd
BSE:539479
|
4.5T INR |
Loading...
|
|
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
46.2B USD |
Loading...
|
|
| CH |
G
|
Galderma Group AG
SIX:GALD
|
34.1B CHF |
Loading...
|
|
| US |
R
|
Reddit Inc
NYSE:RDDT
|
34.2B USD |
Loading...
|
Market Distribution
Other Profitability Ratios
NKGen Biotech Inc
Glance View
NKGen Biotech Inc is a US-based company operating in industry. The company is headquartered in Santa Ana, California. The company went IPO on 2021-05-21. NKGen Biotech, Inc. is a clinical-stage biotechnology company. The firm is focused on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapies to treat neurodegenerative and oncological diseases utilizing its (SuperNK) SNK (super-activated) platform. SNK involves the infusion of one’s own activated NK cells into the body to improve immune system function, eliminate diseased or abnormal cells and prevent recurrence. SNK uses pure NK cells harvested from the patient’s blood, activated and infused back into the patient’s body. SNK has a therapeutic potential within the areas of cancer, autoimmune and neurodegenerative diseases. Autologous NK cell immunotherapy is a treatment that provides immune enhancement using pure NK cells harvested from a patient’s body. The company is also focused on conducting clinical trials with its super-activated NK cell therapy in patients with neurodegenerative disease (SNK01) and cancer (SNK02).